Traver Hart

Traver Hart

Auto-generated profile, based on publicly available information

Traver Hart

Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Cell
Verified
Journal Article
Closed access
THTraver Hart
Traver Hart
MCMegha Chandrashekhar
Megha Chandrashekhar
MAMichael Aregger
Michael Aregger
ZSZachary Steinhart
Zachary Steinhart
KBKevin R. Brown
Kevin R. Brown
JMJason Moffat
Jason Moffat

1 August 2012 in Cell
Verified
Journal Article
Closed access
PHPierre C. Havugimana
Pierre C. Havugimana
GHG. Traver Hart
G. Traver Hart
TNTamás Nepusz
Tamás Nepusz
HYHaixuan Yang
Haixuan Yang
ATAndrei L. Turinsky
Andrei L. Turinsky
AEAndrew Emili
Andrew Emili

1 August 2017 in G3: Genes, Genomes, Genetics
Verified
Journal Article
Open access
PDF file
THTraver Hart
Traver Hart
ATAmy Hin Yan Tong
Amy Hin Yan Tong
KCKatie Chan
Katie Chan
JLJolanda Van Leeuwen
Jolanda Van Leeuwen
ASAshwin Seetharaman
Ashwin Seetharaman
JMJason Moffat
Jason Moffat
The adaptation of CRISPR/SpCas9 technology to mammalian cell lines is transforming the study of human functional genomics. Pooled libraries of CRISPR guide RNAs (gRNAs) targeting human protein-coding genes and encoded in viral vectors have been used to systematically create gene knockouts in a variety of human cancer and immortalized cell lines, in an effort to identify whether these knockouts cause cellular fitness defects. Previous work has shown that CRISPR screens are more sensitive and specific than pooled-library shRNA screens in similar assays, but currently there exists significant variability across CRISPR library designs and experimental protocols. In this study, we reanalyze 17 genome-scale knockout screens in human cell lines from three research groups, using three different genome-scale gRNA libraries. Using the Bayesian Analysis of Gene Essentiality algorithm to identify essential genes, we refine and expand our previously defined set of human core essential genes from 360 to 684 genes. We use this expanded set of reference core essential genes, CEG2, plus empirical data from six CRISPR knockout screens to guide the design of a sequence-optimized gRNA library, the Toronto KnockOut version 3.0 (TKOv3) library. We then demonstrate the high effectiveness of the library relative to reference sets of essential and nonessential genes, as well as other screens using similar approaches. The optimized TKOv3 library, combined with the CEG2 reference set, provide an efficient, highly optimized platform for performing and assessing gene knockout screens in human cell lines.

1 January 2006 in Genome Biology
Verified
Journal Article
Open access
PDF file
GHG Traver Hart
G Traver Hart
ARArun K Ramani
Arun K Ramani
EMEdward M Marcotte
Edward M Marcotte
We estimate the full yeast protein-protein interaction network to contain 37,800-75,500 interactions and the human network 154,000-369,000, but owing to a high false-positive rate, current maps are roughly only 50% and 10% complete, respectively. Paradoxically, releasing raw, unfiltered assay data might help separate true from false interactions.

1 July 2014 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
THTraver Hart
Traver Hart
KBKevin R Brown
Kevin R Brown
FSFabrice Sircoulomb
Fabrice Sircoulomb
RRRobert Rottapel
Robert Rottapel
JMJason Moffat
Jason Moffat
Technological advancement has opened the door to systematic genetics in mammalian cells. Genome‐scale loss‐of‐function screens can assay fitness defects induced by partial gene knockdown, using RNA interference, or complete gene knockout, using new CRISPR techniques. These screens can reveal the basic blueprint required for cellular proliferation. Moreover, comparing healthy to cancerous tissue can uncover genes that are essential only in the tumor; these genes are targets for the development of specific anticancer therapies. Unfortunately, progress in this field has been hampered by off‐target effects of perturbation reagents and poorly quantified error rates in large‐scale screens. To improve the quality of information derived from these screens, and to provide a framework for understanding the capabilities and limitations of CRISPR technology, we derive gold‐standard reference sets of essential and nonessential genes, and provide a Bayesian classifier of gene essentiality that outperforms current methods on both RNAi and CRISPR screens. Our results indicate that CRISPR technology is more sensitive than RNAi and that both techniques have nontrivial false discovery rates that can be mitigated by rigorous analytical methods.

1 January 2013 in BMC Genomics
Verified
Journal Article
Open access
PDF file
THTraver Hart
Traver Hart
HKH K Komori
H K Komori
SLSarah LaMere
Sarah LaMere
KPKatie Podshivalova
Katie Podshivalova
DSDaniel R Salomon
Daniel R Salomon
Early application of second-generation sequencing technologies to transcript quantitation (RNA-seq) has hinted at a vast mammalian transcriptome, including transcripts from nearly all known genes, which might be fully measured only by ultradeep sequencing. Subsequent studies suggested that low-abundance transcripts might be the result of technical or biological noise rather than active transcripts; moreover, most RNA-seq experiments did not provide enough read depth to generate high-confidence estimates of gene expression for low-abundance transcripts. As a result, the community adopted several heuristics for RNA-seq analysis, most notably an arbitrary expression threshold of 0.3 - 1 FPKM for downstream analysis. However, advances in RNA-seq library preparation, sequencing technology, and informatic analysis have addressed many of the systemic sources of uncertainty and undermined the assumptions that drove the adoption of these heuristics. We provide an updated view of the accuracy and efficiency of RNA-seq experiments, using genomic data from large-scale studies like the ENCODE project to provide orthogonal information against which to validate our conclusions.